Nuclear Accumulation of E-Cadherin Correlates with Loss of Cytoplasmic Membrane Staining and Invasion in Pituitary Adenomas

被引:76
作者
Elston, Marianne S. [1 ]
Gill, Anthony J. [2 ]
Conaglen, John V. [4 ]
Clarkson, Adele [2 ]
Cook, Raymond J. [3 ]
Little, Nicholas S. [3 ]
Robinson, Bruce G. [1 ]
Clifton-Bligh, Roderick J. [1 ]
McDonald, Kerrie L. [1 ]
机构
[1] Univ Sydney, Kolling Inst Med Res, Hormones & Canc Grp, Canc Genet Unit, Sydney, NSW 2006, Australia
[2] Royal N Shore Hosp, Dept Anat Pathol, St Leonards, NSW, Australia
[3] Royal N Shore & N Shore Private Hosp, Dept Neurosurg, St Leonards, NSW 2065, Australia
[4] Univ Auckland, Waikato Clin Sch, Hamilton 3240, New Zealand
基金
英国医学研究理事会;
关键词
SUPPRESSOR GENE; DOWN-REGULATION; BETA-CATENIN; EXPRESSION; TUMOR; LOCALIZATION; METHYLATION; MUTATIONS; PATHWAY;
D O I
10.1210/jc.2008-2075
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Context: Loss of the cell adhesion protein E-cadherin is associated with invasion and metastasis in a number of malignancies. Recent studies have highlighted that loss of E-cadherin cell membrane expression may be accompanied by its detection in the nucleus, suggesting cellular redistribution during neoplasia. Pituitary tumors, although typically benign, may be locally invasive, and loss of membranous E-cadherin has been reported as a marker of invasion in prolactinomas. Objective: Our objective was to study E-cadherin expression in pituitary adenomas, specifically whether nuclear redistribution occurs in this setting. Methods: Immunohistochemistry, RT-PCR, and direct sequencing were performed. Results: Strong cytoplasmic membrane staining was present in all eight normal samples but completely absent in 21 of 44 adenomas (48%) with weak staining in an additional 11 adenomas using an antibody against the extra cellulardomain of E-cadherin. To identify nuclear translocation of the protein, immunohistochemistry was performed using an antibody against the cytoplasmic domain. Nuclear staining was present in 38 of 44 adenomas (86%) and absent in normal tissue. Nuclear E-cadherin inversely correlated with loss of E-cadherin cytoplasmic membrane staining and was associated with tumor invasion (P = 0.009). To investigate the mechanism of nuclear redistribution of E-cadherin, we performed RT-PCR of mRNA and sequenced tumor DNA. E-cadherin mRNA expression was reduced in only one of 30 samples (3%). No mutations were detected. Conclusions: E-cadherin was frequently lost at the cytoplasmic membrane but detected in the nucleus, suggesting that cleavage of the extracellular domain and nuclear translocation of E-cadherin is a common event that may determine local invasion in pituitary adenomas. (J Clin Endocrinol Metab 94: 1436-1442, 2009)
引用
收藏
页码:1436 / 1442
页数:7
相关论文
共 28 条
[1]
The cytogenesis and pathogenesis of pituitary adenomas [J].
Asa, SL ;
Ezzat, S .
ENDOCRINE REVIEWS, 1998, 19 (06) :798-827
[2]
DISSECTING TUMOR-CELL INVASION - EPITHELIAL-CELLS ACQUIRE INVASIVE PROPERTIES AFTER THE LOSS OF UVOMORULIN-MEDIATED CELL CELL-ADHESION [J].
BEHRENS, J ;
MAREEL, MM ;
VANROY, FM ;
BIRCHMEIER, W .
JOURNAL OF CELL BIOLOGY, 1989, 108 (06) :2435-2447
[3]
E-cadherin is a tumour invasion suppressor gene mutated in human lobular breast cancers [J].
Berx, G ;
CletonJansen, AM ;
Nollet, F ;
deLeeuw, WJF ;
vandeVijver, MJ ;
Cornelisse, C ;
vanRoy, F .
EMBO JOURNAL, 1995, 14 (24) :6107-6115
[4]
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria [J].
Brooks-Wilson, AR ;
Kaurah, P ;
Suriano, G ;
Leach, S ;
Senz, J ;
Grehan, N ;
Butterfield, YSN ;
Jeyes, J ;
Schinas, J ;
Bacani, J ;
Kelsey, M ;
Ferreira, P ;
MacGillivray, B ;
Macleod, P ;
Micek, M ;
Ford, J ;
Foulkes, W ;
Australie, K ;
Greenberg, C ;
LaPointe, M ;
Gilpin, C ;
Nikkel, S ;
Gilchrist, D ;
Hughes, R ;
Jackson, CE ;
Monaghan, KG ;
Oliveira, MJ ;
Seruca, R ;
Gallinger, S ;
Caldas, C ;
Huntsman, D .
JOURNAL OF MEDICAL GENETICS, 2004, 41 (07) :508-517
[6]
Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors [J].
Chetty, Runjan ;
Serra, Stefano ;
Asa, Sylvia L. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2008, 32 (03) :413-419
[7]
High prevalence of pituitary adenomas: A cross-sectional study in the province of Liege, Belgium [J].
Daly, Adrian F. ;
Rixhon, Martine ;
Adam, Christelle ;
Dempegioti, Anastasia ;
Tichomirowa, Maria A. ;
Beckers, Albert .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (12) :4769-4775
[8]
Wnt pathway inhibitors are strongly down-regulated in pituitary tumors [J].
Elston, Marianne S. ;
Gill, Anthony J. ;
Conaglen, John V. ;
Clarkson, Adele ;
Shaw, Janet M. ;
Law, Andrew J. J. ;
Cook, Raymond J. ;
Little, Nicholas S. ;
Clifton-Bligh, Roderick J. ;
Robinson, Bruce G. ;
McDonald, Kerrie L. .
ENDOCRINOLOGY, 2008, 149 (03) :1235-1242
[9]
A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus [J].
Ferber, Emma C. ;
Kajita, Mihoko ;
Wadlow, Anthony ;
Tobiansky, Lara ;
Niessen, Carien ;
Ariga, Hiroyoshi ;
Daniel, Juliet ;
Fujita, Yasuyuki .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (19) :12691-12700
[10]
E-CADHERIN-MEDIATED CELL CELL-ADHESION PREVENTS INVASIVENESS OF HUMAN CARCINOMA-CELLS [J].
FRIXEN, UH ;
BEHRENS, J ;
SACHS, M ;
EBERLE, G ;
VOSS, B ;
WARDA, A ;
LOCHNER, D ;
BIRCHMEIER, W .
JOURNAL OF CELL BIOLOGY, 1991, 113 (01) :173-185